Recombinant Expression and Functional Assessment of Uricase from a Pertinent Origin of the Enzyme, Streptomyces sp. Strain 17-1
- PMID: 38827344
- PMCID: PMC11139450
- DOI: 10.30498/ijb.2024.379614.3602
Recombinant Expression and Functional Assessment of Uricase from a Pertinent Origin of the Enzyme, Streptomyces sp. Strain 17-1
Abstract
Background: Uricase or urate oxidase, as a therapeutic enzyme, is extensively applied to oxidize accumulated uric acid in the body to soluble form to treat related illnesses.
Objectives: This study was conducted with the aim of searching for potential sources of uricase-producing Streptomyces from Eshtehard salt desert in Alborz province, Iran and heterologous expression, purification and functional assay of the enzyme.
Materials and methods: Main screening was conducted by cultivation of the strains on a medium enriched with 0.3 percent (w/v) uric acid. The uricase gene from the most potent strain was then recombinantly expressed in E. coli BL21 (DL3).
Results: Out of the tested strains, only seven showed uricase activity. The highest level of native uricase activity (11.5735 U.mL-1) belonged to strain 17-1, which had the closest similarity to Streptomyces nigra. A recombinant uricase with a molecular mass of approximately 38 kDa was produced. The purified uricase exhibited a specific activity of about 28.29±0.59 U.mg-1, which is among the highest level of uricase activity reported by other studies.
Conclusions: This enzyme is a promising candidate for further applicable investigations and large-scale production in terms of its large volume of soluble expression and selective competitive activity.
Keywords: Actinobacteria; Uricase; pET28a+; Streptomyces.
Copyright: © 2021 The Author(s); Published by Iranian Journal of Biotechnology.
Conflict of interest statement
There is no conflict of interest.
Figures




Similar articles
-
Cloning, Heterologous Expression, and Characterization of a Neutral Uricase from Arthrobacter sp. CSAJ-16 in Cangshan Mountain.Pol J Microbiol. 2023 Sep 20;72(3):277-283. doi: 10.33073/pjm-2023-027. eCollection 2023 Sep 1. Pol J Microbiol. 2023. PMID: 37725900 Free PMC article.
-
Cloning, Expression, and Purification of Recombinant Uricase Enzyme from Pseudomonas aeruginosa Ps43 Using Escherichia coli.J Microbiol Biotechnol. 2015 Jun;25(6):887-92. doi: 10.4014/jmb.1410.10041. J Microbiol Biotechnol. 2015. PMID: 25588559
-
Isolation and Characterization of Highly Active Uricase from Alcaligenes spp. Strain UR1.Pol J Microbiol. 2025 Mar 26;74(1):106-129. doi: 10.33073/pjm-2025-009. eCollection 2025 Mar 1. Pol J Microbiol. 2025. PMID: 40146794 Free PMC article.
-
The Role of Uric Acid in Human Health: Insights from the Uricase Gene.J Pers Med. 2023 Sep 20;13(9):1409. doi: 10.3390/jpm13091409. J Pers Med. 2023. PMID: 37763176 Free PMC article. Review.
-
Use of the uricase-inhibited rat as an animal model in toxicology.Clin Toxicol. 1978;13(1):47-74. doi: 10.3109/15563657808988228. Clin Toxicol. 1978. PMID: 367691 Review.
Cited by
-
Pharmaceutical applications of halophilic enzymes.Heliyon. 2025 Feb 17;11(4):e42754. doi: 10.1016/j.heliyon.2025.e42754. eCollection 2025 Feb 28. Heliyon. 2025. PMID: 40066035 Free PMC article. Review.
References
-
- Kratzer JT. Reengineering a human-like uricase for the treatment of gout (PhD thesis) . Geo Ins Technol. 2013
-
- Nelapati AK, Meena S K. An Approach to Increase the Efficiency of Uricase by Computational Mutagenesis. Phys Chem Res. 2023;11(3):481–491. doi: 10.22036/pcr.2022.345329.2115. - DOI
-
- Torres-Acosta MA, Aguilar-Yáñez JM, Rito-Palomares M, Titchener-Hooker NJ. Economic analysis of uricase production under uncertainty: Contrast of chromatographic purification and aqueous two-phase extraction (with and without PEG recycle) . Biotechnol Progr. 2016;32(1):126–133. doi: 10.1002/btpr.2200. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources